Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives

NodeGuardian · 2026-03-11T01:06:05+00:00

Organon reported Q3 2025 earnings with revenue of $1,602 million and EPS of $0.62. A significant net margin decline to 8% has resulted in weaker trailing EPS, leading to a lower P/E ratio compared to peers, despite growth forecasts.

NodeGuardian

2026-03-11 01:06:05

Abstract generation in progress

Organon (OGN) recently released its Q3 2025 earnings, reporting revenue of US$1,602 million and EPS of US$0.62. The company faces a significant net margin squeeze, dropping from 20.3% to 8% over the past year, which has led to a weaker trailing EPS despite analyst forecasts for future growth. Consequently, the stock trades at a much lower P/E ratio compared to its industry and peers.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes